Paper4913403
Protection against Marek's disease by vaccination with a herpesvirus of turkeys.
Okazaki W and 2 others. Avian Dis, 1970. Cited by 410 papers, by iCite.
Cite this record
ConductScience Library. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Papers, record 4913403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4913403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Avian Leukosis | Major topic |
| Herpesviridae | Major topic |
| Viral Vaccines | Major topic |
| Aging | |
| Animals | |
| Antibodies | |
| Chickens | |
| Culture Techniques | |
| Fluorescent Antibody Technique | |
| Turkeys | |
| Vaccination |
Source PubMed
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 410 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42043260 | Development of a Multiplex PCR Method for Efficient Differential Diagnosis of Clinical Cases and Vaccine Immunization of Marek's Disease. | Viruses | 2026 | https://conductscience.org/library/papers/42043260 | PubMed |
| 41894092 | The use of an avian macrophage-like cell line (HD11) transduced with recombinant lentiviruses to dissect the immunomodulatory role of Marek's disease virus gene products. | Virus Genes | 2026 | https://conductscience.org/library/papers/41894092 | PubMed |
| 40559546 | The Requirement of Turkey Herpesvirus (HVT) Glycoprotein C During Natural Infection in Chickens and Turkeys. | Pathogens | 2025 | https://conductscience.org/library/papers/40559546 | PubMed |
| 40417002 | Application of CRISPR/Cas gene editing for infectious disease control in poultry. | Open Life Sci | 2025 | https://conductscience.org/library/papers/40417002 | PubMed |
| 39861844 | The Meq Genes of Nigerian Marek's Disease Virus (MDV) Field Isolates Contain Mutations Common to Both European and US High Virulence Strains. | Viruses | 2024 | https://conductscience.org/library/papers/39861844 | PubMed |
| 39319014 | From ancient remedies to modern miracles: tracing the evolution of vaccines and their impact on public health. | 3 Biotech | 2024 | https://conductscience.org/library/papers/39319014 | PubMed |
| 39036034 | Comparative analysis of multiple consensus genomes of the same strain of Marek's disease virus reveals intrastrain variation. | Virus Evol | 2024 | https://conductscience.org/library/papers/39036034 | PubMed |
| 38812565 | Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/38812565 | PubMed |
| 37515122 | Emerging Hypervirulent Marek's Disease Virus Variants Significantly Overcome Protection Conferred by Commercial Vaccines. | Viruses | 2023 | https://conductscience.org/library/papers/37515122 | PubMed |
| 36992357 | Role of T Cells in Vaccine-Mediated Immunity against Marek's Disease. | Viruses | 2023 | https://conductscience.org/library/papers/36992357 | PubMed |
| 36890573 | Marek's disease in chicken farms from Northwest Ethiopia: gross pathology, virus isolation, and molecular characterization. | Virol J | 2023 | https://conductscience.org/library/papers/36890573 | PubMed |
| 36777028 | Efficacy of a recombinant turkey herpesvirus (H9) vaccine against H9N2 avian influenza virus in chickens with maternal-derived antibodies. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36777028 | PubMed |
| 35812862 | Rapid, Sensitive, and Species-Specific Detection of Conventional and Recombinant Herpesvirus of Turkeys Vaccines Using Loop-Mediated Isothermal Amplification Coupled With a Lateral Flow Device Readout. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/35812862 | PubMed |
| 35694305 | Identification of a Novel Insertion Site HVT-005/006 for the Generation of Recombinant Turkey Herpesvirus Vector. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35694305 | PubMed |
| 35632592 | The World of Antiherpetic Vaccines and Drugs, 2022. | Viruses | 2022 | https://conductscience.org/library/papers/35632592 | PubMed |
| 35458523 | A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens. | Viruses | 2022 | https://conductscience.org/library/papers/35458523 | PubMed |
| 34977551 | B cells do not play a role in vaccine-mediated immunity against Marek's disease. | Vaccine X | 2022 | https://conductscience.org/library/papers/34977551 | PubMed |
| 34200544 | Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research. | Microorganisms | 2021 | https://conductscience.org/library/papers/34200544 | PubMed |
| 34070255 | Latest Insights into Unique Open Reading Frames Encoded by Unique Long (UL) and Short (US) Regions of Marek's Disease Virus. | Viruses | 2021 | https://conductscience.org/library/papers/34070255 | PubMed |
| 33669421 | A Novel Effective and Safe Vaccine for Prevention of Marek's Disease Caused by Infection with a Very Virulent Plus (vv+) Marek's Disease Virus. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33669421 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4913403
GET https://conductscience.org/api/papers/v1/4913403/cited_by?page=2